Effects of Intraoperative Local Pain Cocktail Injections on Early Function and Patient-Reported Outcomes: A Randomized Controlled Trial

被引:2
|
作者
Ihejirika-Lomedico, Rivka [1 ]
Solasz, Sara [1 ]
Lorentz, Nathan A. [1 ]
Egol, Kenneth [1 ]
Leucht, Philipp [1 ,2 ,3 ]
NYU Hip Fracture Res Grp
机构
[1] NYU Langone Hlth, Dept Orthoped Surg, New York, NY USA
[2] NYU, Grossman Sch Med, Dept Cell Biol, New York, NY USA
[3] NYU Langone Hlth, Dept Orthoped Surg, 550 First Ave,MSB 251, New York, NY 10016 USA
关键词
hip fracture; anesthesia; perioperative analgesia; pain management; safety; MULTIMODAL DRUG INJECTION; CLINICALLY IMPORTANT DIFFERENCE; TOTAL KNEE ARTHROPLASTY; REGIONAL ANESTHESIA; POSTOPERATIVE PAIN; LIPOSOMAL BUPIVACAINE; FRACTURE FIXATION; TOTAL HIP; EFFICACY; MANAGEMENT;
D O I
10.1097/BOT.0000000000002628
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Objective:To determine whether a perioperative pain cocktail injection improves postoperative pain, ambulation distance, and long-term outcomes in patients with hip fracture.Design:Prospective, single-blinded, randomized controlled trial.Setting:Academic Medical Center.Patients/Participants:Patients with OTA/AO 31A1-3 and 31B1-3 fractures undergoing operative fixation, excluding arthroplasty.Intervention:Multimodal local injection of bupivacaine (Marcaine), morphine sulfate (Duramorph), ketorolac (Toradol) given at the fracture site at the time of hip fracture surgery (Hip Fracture Injection, HiFI).Main Outcome Measurements:Patient-reported pain, American Pain Society Patient Outcome Questionnaire (APS-POQ), narcotic usage, length of stay, postoperative ambulation, Short Musculoskeletal Function Assessment.Results:Seventy-five patients were in the treatment group and 109 in the control group. Patients in the HiFI group had a significant reduction in pain and narcotic usage compared with the control group on postoperative day (POD) 0 (P < 0.01). Based on the APS-POQ, patients in the control group had a significantly harder time falling asleep, staying asleep, and experienced increased drowsiness on POD 1 (P < 0.01). Patient ambulation distance was greater on POD 2 (P < 0.01) and POD 3 (P < 0.05) in the HiFI group. The control group experienced more major complications (P < 0.05). At 6-week postop, patients in the treatment group reported significantly less pain, better ambulatory function, less insomnia, less depression, and better satisfaction than the control group as measured by the APS-POQ. The Short Musculoskeletal Function Assessment bothersome index was also significantly lower for patients in the HiFI group, P < 0.05.Conclusions:Intraoperative HiFI not only improved early pain management and increased ambulation in patients undergoing hip fracture surgery while in the hospital, it was also associated with early improved health-related quality of life after discharge.
引用
收藏
页码:433 / 439
页数:7
相关论文
共 50 条
  • [31] The APPROACH trial: Assessing pain, patient-reported outcomes, and complementary and integrative health
    Zeliadt, Steven B.
    Coggeshall, Scott
    Thomas, Eva
    Gelman, Hannah
    Taylor, Stephanie L.
    CLINICAL TRIALS, 2020, 17 (04) : 351 - 359
  • [32] Computerized patient-reported symptom assessment in radiotherapy: a pilot randomized, controlled trial
    Erik K. Fromme
    Emma B. Holliday
    Lillian M. Nail
    Karen S. Lyons
    Michelle R. Hribar
    Charles R. Thomas
    Supportive Care in Cancer, 2016, 24 : 1897 - 1906
  • [33] Computerized patient-reported symptom assessment in radiotherapy: a pilot randomized, controlled trial
    Fromme, Erik K.
    Holliday, Emma B.
    Nail, Lillian M.
    Lyons, Karen S.
    Hribar, Michelle R.
    Thomas, Charles R., Jr.
    SUPPORTIVE CARE IN CANCER, 2016, 24 (04) : 1897 - 1906
  • [34] Patient-Reported Outcomes Following Systemic Antibiotic Adjunct to Nonsurgical Treatment of Periodontitis: A Randomized Controlled Clinical Trial
    Parhizkar, Parastoo
    Yaghini, Jaber
    Fakheran, Omid
    CLINICAL AND EXPERIMENTAL DENTAL RESEARCH, 2025, 11 (01):
  • [35] Effect of systemic antibiotics on clinical and patient-reported outcomes of implant therapy - a multicenter randomized controlled clinical trial
    Tan, Wah Ching
    Ong, Marianne
    Han, Jie
    Mattheos, Nikos
    Pjetursson, Bjarni E.
    Tsai, Alex Yi-Min
    Sanz, Ignacio
    Wong, May C. M.
    Lang, Niklaus P.
    CLINICAL ORAL IMPLANTS RESEARCH, 2014, 25 (02) : 185 - 193
  • [36] Effects of upadacitinib on atopic dermatitis signs, symptoms and patient-reported outcomes from a phase IIb randomized, placebo-controlled trial
    De Bruin-Weller, M. S.
    Guttman-Yassky, E.
    Forman, S. B.
    Bodhani, A.
    Chen, S.
    Pangan, A. L.
    Teixeira, H. D.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (01) : E13 - E13
  • [37] Effects of PR-Fampridine on gait pattern and patient-reported outcomes: a cross-over, randomized, placebo-controlled trial
    Valet, M.
    El Sankari, S.
    Van Pesch, V.
    Boulet, S.
    Lejeune, T.
    Stoquart, G.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 66 - 67
  • [38] Evaluating the effect of weekly patient-reported symptom monitoring on trial outcomes: results of the Eczema Monitoring Online randomized controlled trial
    Baker, Arabella
    Mitchell, Eleanor J.
    Partlett, Christopher
    Thomas, Kim S.
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 189 (02) : 180 - 187
  • [39] A randomised, controlled trial of the effects of a mobile telehealth intervention on clinical and patient-reported outcomes in people with poorly controlled diabetes
    Baron, Justine S.
    Hirani, Shashivadan
    Newman, Stanton P.
    JOURNAL OF TELEMEDICINE AND TELECARE, 2017, 23 (02) : 207 - 216
  • [40] A randomized controlled trial of routine financial toxicity screening via electronic patient-reported outcomes (AFT-39).
    Blinder, Victoria Susana
    Deal, Allison Mary
    Ginos, Brenda F.
    Jansen, Jennifer
    Dueck, Amylou C.
    Mazza, Gina L.
    Henson, Sydney
    Carr, Philip M.
    Rogak, Lauren J.
    Weiss, Anna
    Rapperport, Anna
    Spears, Patricia
    Gany, Francesca
    Schrag, Deborah
    Basch, Ethan
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 180 - 180